Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Rise in Stage 4 Cancer Rates Due to the Covid Pandemic

Rise in Stage 4 Cancer Rates Due to the Covid Pandemic

JAMA Network Open published research on 15 February 2022 showing that the marked decline in cancer screening for early detection during the first year of the COVID-19 Pandemic led to a significant increase in metastatic (advanced-stage) breast and colon cancer among patients presenting for care.

The authors, led by Dr. Jade Zifei Zhou, a hematology/oncology specialist at the University of California, San Diego center, say, "The number of patients presenting at late, incurable stages is increasing".

As the pandemic intensifies, nonurgent medical procedures are put on hold; postponements of mammography, colonoscopy and other cancer screening have raised concerns about future problems. For example, in June 2020, tens of thousands of excess cancer deaths by 2030 in the US alone due to missed screening and treatment delays were predicted.

The California team compared the number of patients with stage 1 and stage 4 cancer who came to their cancer centers for a new diagnosis or second opinion in 2019 and in 2020, the first year of the pandemic. The study included more than 500 patients, whose mean age was 58 and 90% of whom were women.

  • In 2019, 63.9% of breast cancer patients presented with stage 1 disease, compared with 51.3% in 2020. Conversely, only 1.9% were diagnosed at stage 4 in 2019, rising to 6.2% in 2020.
  • The figures were even worse between January and March 2021, when only 41.9% of women presented with stage 1 and 8% with stage 4 breast cancer.

The situation was similar for colon cancer, although the findings were not statistically significant because there were fewer patients:

After the pandemic began, the proportion of patients presenting with stage 1 colon cancer fell from 17.8% (eight patients) to 14.6% (six patients), while those diagnosed at stage 4 increased from 6.7% (three) to 19.5% (eight).

Across all cancer types, diagnosis at stage 1 fell from 31.9% in 2019 to 29% in 2020, while presentation at stage 4 rose from 26% to 26.4%.

Cancer screening is not the only thing being postponed or disrupted; we also know that many people with cancer symptoms are reluctant to see a doctor.

The message from this research is that patients whose early diagnosis was disrupted during the pandemic should be encouraged to resume treatment as soon as possible, and cancer screening should continue with greater awareness than before.

Sources

1. Jade Zifei Zhou, Shelly Kane, Celia Ramsey, et al. Comparison of Early- and Late-Stage Breast and Colorectal Cancer Diagnoses During vs Before the COVID-19 Pandemic. JAMA Network Open, 15 Feb 2022.

2. Increase in Late-Stage Cancer Diagnoses After Pandemic - Medscape - Feb 15, 2022.

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Rise in Stage 4 Cancer Rates Due to the Covid Pandemic

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy